Recent advances and challenges in antigen engineering & vaccine development

dc.contributor.advisorMaynard, Jennifer Anne, 1974-
dc.creatorKornahrens, William Josephen
dc.date.accessioned2014-10-02T20:45:53Zen
dc.date.accessioned2018-01-22T22:26:40Z
dc.date.available2018-01-22T22:26:40Z
dc.date.issued2014-05en
dc.date.submittedMay 2014en
dc.date.updated2014-10-02T20:45:54Zen
dc.descriptiontexten
dc.description.abstractVaccines play a vital role in public health by preventing infectious disease across the globe. Vaccine formulations represent a weakened form of a microbe or toxin that is injected into the human body to elicit an immune response, generating antibodies to protect against a future infection. To this day, it is a challenge to identify and engineer important antigens and epitopes to focus this immune response in a safe and effective manner. The example of Bordetella pertussis is used to highlight the problems and lessons learned in designing a vaccine for this global epidemic. In particular, this review will focus on the advantages and disadvantages of chemical versus genetic detoxification and whole cell versus acellular vaccines in the context of pertussis. The latter part of this review will provide a summary of general strategies, such as epitope mapping and manipulation, synthesis of truncated variants, reverse vaccinology, and structural vaccinology, that have been successful in addressing increasingly complex diseases. Collectively, these techniques provide an invaluable set of tools to focus the immune response by finding and engineering specific antigens and epitopes.en
dc.description.departmentChemical Engineeringen
dc.format.mimetypeapplication/pdfen
dc.identifier.urihttp://hdl.handle.net/2152/26243en
dc.language.isoenen
dc.subjectVaccineen
dc.subjectEpitopeen
dc.subjectPertussisen
dc.subjectEngineeringen
dc.subjectAntigenen
dc.subjectVaccinologyen
dc.titleRecent advances and challenges in antigen engineering & vaccine developmenten
dc.typeThesisen

Files